| Operating Results For The Company's Reportable Segments |
Reportable segment data as of, or for, each period presented in the consolidated statements of income and comprehensive income, the consolidated balance sheets, and the consolidated statements of cash flows is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2026 | | Three Months Ended June 30, 2025 | | Tobacco Operations | | Ingredients Operations | | Consolidated | | Tobacco Operations | | Ingredients Operations | | Consolidated | | Sales and other operating revenues | $ | 437,128 | | | $ | 86,651 | | | $ | 523,779 | | | $ | 504,696 | | | $ | 89,066 | | | $ | 593,762 | | | Cost of goods sold | (367,087) | | | (73,604) | | | (440,691) | | | (407,867) | | | (71,768) | | | (479,635) | | | Selling, general and administrative expenses | (46,064) | | | (10,521) | | | (56,585) | | | (44,754) | | | (12,037) | | | (56,791) | | | Corporate overhead allocated to the segments | (21,021) | | | (3,186) | | | (24,207) | | | (18,840) | | | (3,561) | | | (22,401) | | Equity in pretax earnings (loss) of unconsolidated affiliates(1) | 510 | | | — | | | 510 | | | 2,435 | | | — | | | 2,435 | | | Segment operating income (loss) | 3,466 | | | (660) | | | 2,806 | | | 35,670 | | | 1,700 | | | 37,370 | | Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates(1) | | (510) | | | | | | | (2,435) | | Restructuring and impairment costs (2) | | — | | | | | | | (1,122) | | | | | | | | | | | | | | | Consolidated operating income | | $ | 2,296 | | | | | | | $ | 33,813 | |
(1)Equity in pretax earnings (loss) of unconsolidated affiliates is included in segment operating income (Tobacco Operations), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income. (2)Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income. See Note 2 for additional information. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Segment Assets | | Accounts Receivable, net | | June 30, 2026 | | June 30, 2025 | | March 31, 2026 | | June 30, 2026 | | June 30, 2025 | | March 31, 2026 | | Tobacco Operations | $ | 2,563,429 | | | $ | 2,652,407 | | | $ | 2,300,491 | | | $ | 296,659 | | | $ | 366,317 | | | $ | 508,247 | | | Ingredients Operations | 472,038 | | | 536,900 | | | 466,276 | | | 51,377 | | | 57,840 | | | 55,617 | | | Consolidated total | $ | 3,035,467 | | | $ | 3,189,307 | | | $ | 2,766,767 | | | $ | 348,036 | | | $ | 424,157 | | | $ | 563,864 | | | | | | | | | | | | | | | Goodwill, net | | Intangibles, net | | June 30, 2026 | | June 30, 2025 | | March 31, 2026 | | June 30, 2026 | | June 30, 2025 | | March 31, 2026 | | Tobacco Operations | $ | 97,672 | | | $ | 97,796 | | | $ | 97,688 | | | $ | 55 | | | $ | 45 | | | $ | 47 | | | Ingredients Operations | 75,007 | | | 116,068 | | | 75,007 | | | 46,538 | | | 55,192 | | | 48,557 | | | Consolidated total | $ | 172,679 | | | $ | 213,864 | | | $ | 172,695 | | | $ | 46,593 | | | $ | 55,237 | | | $ | 48,604 | | | | | | | | | | | | | | | | | | | Capital Expenditures | | Depreciation and Amortization | | | | | | Three Months Ended June 30, | | Three Months Ended June 30, | | | | | | 2026 | | 2025 | | 2026 | | 2025 | | Tobacco Operations | $ | 12,535 | | | $ | 7,402 | | | $ | 7,667 | | | $ | 8,216 | | | Ingredients Operations | 3,391 | | | 4,651 | | | 5,093 | | | 5,366 | | | Consolidated total | $ | 15,926 | | | $ | 12,053 | | | $ | 12,760 | | | $ | 13,582 | |
|